These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 8877491)
81. Low-dose gadobenate dimeglumine versus standard dose gadopentetate dimeglumine for contrast-enhanced magnetic resonance imaging of the liver: an intra-individual crossover comparison. Schneider G; Maas R; Schultze Kool L; Rummeny E; Gehl HB; Lodemann KP; Kirchin MA Invest Radiol; 2003 Feb; 38(2):85-94. PubMed ID: 12544071 [TBL] [Abstract][Full Text] [Related]
82. Kinetics of gadobenate dimeglumine in isolated perfused rat liver: MR imaging evaluation. Pastor CM; Planchamp C; Pochon S; Lorusso V; Montet X; Mayer J; Terrier F; Vallee JP Radiology; 2003 Oct; 229(1):119-25. PubMed ID: 12944603 [TBL] [Abstract][Full Text] [Related]
83. Comparison of gadobenate dimeglumine with gadopentetate dimeglumine for magnetic resonance imaging of liver tumors. Kuwatsuru R; Kadoya M; Ohtomo K; Tanimoto A; Hirohashi S; Murakami T; Tanaka Y; Yoshikawa K; Katayama H Invest Radiol; 2001 Nov; 36(11):632-41. PubMed ID: 11606840 [TBL] [Abstract][Full Text] [Related]
84. Effect of different classes of gadolinium-based contrast agents on control and nephrogenic systemic fibrosis-derived fibroblast proliferation. Edward M; Quinn JA; Burden AD; Newton BB; Jardine AG Radiology; 2010 Sep; 256(3):735-43. PubMed ID: 20663970 [TBL] [Abstract][Full Text] [Related]
85. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance]. Campos A; Aznar L; Alamar R; Castelló JV Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023 [No Abstract] [Full Text] [Related]
86. [Use of gadoteridol in MR diagnosis of rheumatoid changes in the joints]. Link TM; Bongartz GM; Böger K; Daldrup H; Schmitz-Linneweber B; Peters PE Radiologe; 1996 Feb; 36(2):141-7. PubMed ID: 8867431 [TBL] [Abstract][Full Text] [Related]
87. [General toxicity study of gadobenate dimeglumine formulation (E7155) (2)--Single dose intravenous toxicity study in dogs]. Sekido T; Sagami F; Tirone P; Morisetti A; Bussi S; Masters RE J Toxicol Sci; 1999 Nov; 24 Suppl 1():7-18. PubMed ID: 10637777 [TBL] [Abstract][Full Text] [Related]
88. [Reproductive and developmental toxicity study of gadobenate dimeglumine formulation (E7155) (3)--Study of embryo-fetal toxicity in rabbits by intravenous administration]. Okuda Y; Sagami F; Tirone P; Morisetti A; Bussi S; Masters RE J Toxicol Sci; 1999 Nov; 24 Suppl 1():79-87. PubMed ID: 10637782 [TBL] [Abstract][Full Text] [Related]
89. Brain penetration and neurological effects of gadobenate dimeglumine in the rat. Luzzani F; Cipolla P; Pélaprat ML; Robert F; Gotti C; Tirone P; de Haën C Acta Radiol; 1997 Mar; 38(2):268-72. PubMed ID: 9093163 [TBL] [Abstract][Full Text] [Related]
90. [General toxicity study of gadobenate dimeglumine formulation (E7155) (4)--4-week repeated dose intravenous toxicity study followed by 4-week recovery period in dogs]. Katsutani N; Sagami F; Tirone P; Morisetti A; Bussi S; Mandella RC J Toxicol Sci; 1999 Nov; 24 Suppl 1():41-60. PubMed ID: 10637779 [TBL] [Abstract][Full Text] [Related]
93. Utility of high-dose contrast enhancement for detecting recurrent herniated intervertebral disks. Nguyen C; An H; Ho KC; Haughton VM; Hasegawa T AJNR Am J Neuroradiol; 1994 Aug; 15(7):1291-7. PubMed ID: 7976941 [TBL] [Abstract][Full Text] [Related]
94. Small bowel angioedema due to intravenous administration of gadobenate dimeglumine. Maarek R; Sellier N; Seror O; Sutter O Diagn Interv Imaging; 2019; 100(7-8):459-460. PubMed ID: 30935862 [No Abstract] [Full Text] [Related]
95. Editorial for "Does the Higher Relaxivity of Gadobenate Dimeglumine Permit Gadolinium Dose-Lowering in MRI of the Central Nervous System? Results of a Retrospective, Parallel Group Comparison". Kanal E J Magn Reson Imaging; 2021 Nov; 54(5):1676-1677. PubMed ID: 34085348 [No Abstract] [Full Text] [Related]
96. The functional effects of gadolinium-DTPA on the isolated perfused rat kidney. Brown PW; Haylor JL; Morcos SK; el Nahas AM Eur J Radiol; 1993 Feb; 16(2):85-9. PubMed ID: 8462585 [TBL] [Abstract][Full Text] [Related]
97. Hepatic transport of gadobenate dimeglumine in TR-rats. de Haën C; Lorusso V; Tirone P Acad Radiol; 1996 Aug; 3 Suppl 2():S452-4. PubMed ID: 8796627 [No Abstract] [Full Text] [Related]
98. Effects of gadolinium-based magnetic resonance imaging contrast media on red blood cells and K562 cancer cells. Supawat B; Moungthong P; Chanloi C; Jindachai N; Tima S; Kothan S; Udomtanakunchai C; Tungjai M J Trace Elem Med Biol; 2020 Dec; 62():126640. PubMed ID: 32932175 [TBL] [Abstract][Full Text] [Related]
99. Diffusion into rat brain of contrast and shift reagents for magnetic resonance imaging and spectroscopy. Preston E; Foster DO NMR Biomed; 1993; 6(5):339-44. PubMed ID: 8268067 [TBL] [Abstract][Full Text] [Related]
100. An evaluation of the integrity of the blood-testis barrier by magnetic resonance imaging. Farghali H; Williams DS; Simplaceanu E; Ho C; Van Thiel DH Magn Reson Med; 1991 Nov; 22(1):81-7. PubMed ID: 1798397 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]